Inhibrx Biosciences, Inc. (INBX)
84.52
+4.24
(+5.28%)
USD |
NASDAQ |
Nov 06, 16:00
84.95
+0.43
(+0.51%)
After-Hours: 20:00
Inhibrx Biosciences EPS Diluted (Quarterly) : -2.339 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.339 |
| March 31, 2026 | -2.146 |
| December 31, 2025 | -2.114 |
| September 30, 2025 | -2.278 |
| June 30, 2025 | -1.852 |
| March 31, 2025 | -2.80 |
| December 31, 2024 | -3.306 |
| Date | Value |
|---|---|
| September 30, 2024 | -3.030 |
| June 30, 2024 | 128.35 |
| March 31, 2024 | -5.437 |
| December 31, 2023 | -6.466 |
| September 30, 2023 | -3.578 |
| June 30, 2023 | -3.250 |
| March 31, 2023 | -3.379 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 0.0183 |
| Amgen, Inc. | 7.077 |
| Anika Therapeutics, Inc. | -0.0232 |
| BioCryst Pharmaceuticals, Inc. | 0.1417 |
| Imunon, Inc. | -0.5412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.65M |
| Total Expenses (Quarterly) | 36.65M |
| Enterprise Value | 1.291B |
| Earnings Yield | -10.50% |
| Normalized Earnings Yield | -10.50 |